105years
(Founded in 1920)
100years
* Over 100 years
Top share in Japan
Leading Company
※In-house estimate
95%
64.1 billion yen
(FY2024)
762
(End of FY2023)
23
Including 1 international site
8.3%
8.0%
30%
(Benchmark ratio) *A minimum annual dividend per share of 30 yen
7.0 billion yen
(FY2024) *ASKA Pharmaceutical
Ratio of female employees*1
32.7%
Ratio of female management positions*2
12.4%
Ratio of female management candidates*1
23.0%
*1 End of FY2023 in ASKA Pharmaceutical *2 As of September 30, 2024 in ASKA Pharmaceutical
Initiatives to Promote the Advancement of Women
100.0%
(FY2023 in ASKA Pharmaceutical)
49.2%
* The rate in FY2023 compared with the rate in FY2013
Decarbonization Initiatives